{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:07:11Z","timestamp":1791893231057,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fondo di Ateneo per la Ricerca","award":["ORME09SPNC"],"award-info":[{"award-number":["ORME09SPNC"]}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["15-05677S"],"award-info":[{"award-number":["15-05677S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004240","name":"Academy of Sciences of the Czech Republic","doi-asserted-by":"crossref","award":["RVO 61388963"],"award-info":[{"award-number":["RVO 61388963"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004240","name":"Academy of Sciences of the Czech Republic","doi-asserted-by":"crossref","award":["RVO 68378050"],"award-info":[{"award-number":["RVO 68378050"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejmech.2015.07.049","type":"journal-article","created":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T06:32:46Z","timestamp":1438410766000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms"],"prefix":"10.1016","volume":"102","author":[{"given":"Maria Rosa","family":"Buemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Ceruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kl\u00e1ra","family":"Posp\u00ed\u0161ilov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Brynda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavl\u00edna","family":"\u0158ez\u00e1\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Gitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2015.07.049_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.07.049_bib2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2174\/138161208783877866","article-title":"The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents","volume":"14","author":"Mincione","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.07.049_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2174\/138161208783877820","article-title":"Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs?","volume":"14","author":"De Simone","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.07.049_bib4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/156802607780636726","article-title":"Carbonic anhydrase inhibitors as anticonvulsant agents","volume":"7","author":"Thiry","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/092986712799034824","article-title":"Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs","volume":"19","author":"Supuran","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib6","doi-asserted-by":"crossref","first-page":"e50860","DOI":"10.1371\/journal.pone.0050860","article-title":"In\u00a0vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2015.07.049_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14728214.2012.664132","article-title":"Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity","volume":"17","author":"Supuran","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.ejmech.2015.07.049_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2015.07.049_bib9","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2015.07.049_bib10","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/cmdc.200700057","article-title":"Exploration of the binding mode of indanesulfonamides as selective inhibitors of human carbonic anhydrase type VII by targeting Lys 91","volume":"2","author":"Thiry","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2015.07.049_bib11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bmc.2012.08.018","article-title":"Purification and characterization of carbonic anhydrase from sheep kidney and effects of sulfonamides on enzyme activity","volume":"21","author":"Demirdag","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bmcl.2012.10.103","article-title":"Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition","volume":"23","author":"Nishimori","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.07.049_bib13","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.2174\/138161210793429788","article-title":"Modulation of carbonic anhydrase 9 (CA9) in human brain cancer","volume":"16","author":"Said","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.07.049_bib14","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII","volume":"17","author":"Guler","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.nucmedbio.2010.02.006","article-title":"Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in\u00a0vivo visualization of carbonic anhydrase IX expression in tumor hypoxia","volume":"37","author":"Akurathi","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2015.07.049_bib16","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1021\/bi802035f","article-title":"Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties","volume":"48","author":"Genis","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2015.07.049_bib17","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1021\/jm701526d","article-title":"Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs","volume":"51","author":"Thiry","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/156802607780636708","article-title":"Carbonic anhydrase inhibitors and the management of cancer","volume":"7","author":"Pastorekova","year":"2007","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib19","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1021\/jm060531j","article-title":"Carbonic anhydrase inhibitors: hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX","volume":"49","author":"De Simone","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib20","doi-asserted-by":"crossref","first-page":"e108068","DOI":"10.1371\/journal.pone.0108068","article-title":"Tumor microenvironmental changes induced by the sulfamate carbonic anhydrase IX inhibitor S4 in a laryngeal tumor model","volume":"9","author":"Meijer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2015.07.049_bib21","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/anie.201310709","article-title":"A\u00a0small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors","volume":"53","author":"Krall","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2015.07.049_bib22","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1073\/pnas.98.4.1918","article-title":"Expression of membrane-associated carbonic anhydrase XIV on neurons and axons in mouse and human brain","volume":"98","author":"Parkkila","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2015.07.049_bib23","first-page":"1","article-title":"Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors","author":"Winum","year":"2014","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib24","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1517\/13543776.2012.698264","article-title":"Sulfonamides: a patent review (2008\u20132012)","volume":"22","author":"Carta","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2015.07.049_bib25","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1021\/jm300818k","article-title":"Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups","volume":"55","author":"D'Ambrosio","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib26","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1021\/jm300878g","article-title":"Tricyclic sulfonamides incorporating benzothiopyrano[4,3-c]pyrazole and pyridothiopyrano[4,3-c]pyrazole effectively inhibit alpha- and beta-carbonic anhydrase: X-ray crystallography and solution investigations on 15 isoforms","volume":"55","author":"Marini","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib27","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.07.049_bib28","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/138161210793429779","article-title":"Carbonic anhydrases: again, and again, and again","volume":"16","author":"Supuran","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.07.049_bib29","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2174\/138161210793429797","article-title":"Carbonic anhydrase inhibition\/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets","volume":"16","author":"Supuran","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2015.07.049_bib30","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/cmdc.201000200","article-title":"Bidentate zinc chelators for alpha-carbonic anhydrases that produce a trigonal bipyramidal coordination geometry","volume":"5","author":"Schulze Wischeler","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2015.07.049_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/med.20068","article-title":"Therapeutic potential of sulfamides as enzyme inhibitors","volume":"26","author":"Winum","year":"2006","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2015.07.049_bib32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/med.20021","article-title":"Sulfamates and their therapeutic potential","volume":"25","author":"Winum","year":"2005","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2015.07.049_bib33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/ml500196t","article-title":"Carbonic anhydrase inhibition with benzenesulfonamides and tetrafluorobenzenesulfonamides obtained via click chemistry","volume":"5","author":"Pala","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.07.049_bib34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib35","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/jm9014026","article-title":"Identification of 3,4-dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme\u2013ligand X-ray studies","volume":"53","author":"Gitto","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib36","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1021\/jm2000213","article-title":"Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides","volume":"54","author":"Mader","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib37","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/cmdc.201000044","article-title":"Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors","volume":"5","author":"Gitto","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2015.07.049_bib38","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1021\/ja057257n","article-title":"Ultrahigh resolution crystal structures of human carbonic anhydrases I and II complexed with \u201ctwo-prong\u201d inhibitors reveal the molecular basis of high affinity","volume":"128","author":"Jude","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2015.07.049_bib39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1107\/S1744309106020446","article-title":"X-ray crystallographic studies reveal that the incorporation of spacer groups in carbonic anhydrase inhibitors causes alternate binding modes","volume":"62","author":"Fisher","year":"2006","journal-title":"Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.ejmech.2015.07.049_bib40","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1021\/ja061574s","article-title":"Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX","volume":"128","author":"Alterio","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2015.07.049_bib41","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm050333c","article-title":"Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II","volume":"48","author":"Menchise","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib43","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/prot.22144","article-title":"Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide","volume":"74","author":"Di Fiore","year":"2009","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2015.07.049_bib44","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2015.07.049_bib45","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/jm5012935","article-title":"Structural insights into carbonic anhydrase IX isoform specificity of carbohydrate-based sulfamates","volume":"57","author":"Moeker","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib46","doi-asserted-by":"crossref","first-page":"523210","DOI":"10.1155\/2014\/523210","article-title":"Hydrophobic substituents of the phenylmethylsulfamide moiety can be used for the development of new selective carbonic anhydrase inhibitors","volume":"2014","author":"De Simone","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ejmech.2015.07.049_bib47","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/bip.22456","article-title":"The structural comparison between membrane-associated human carbonic anhydrases provides insights into drug design of selective inhibitors","volume":"101","author":"Alterio","year":"2014","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejmech.2015.07.049_bib48","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/jm300112w","article-title":"Synthesis, structure-activity relationship studies, and X-ray crystallographic analysis of arylsulfonamides as potent carbonic anhydrase inhibitors","volume":"55","author":"Gitto","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2013.10.071","article-title":"Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors","volume":"71","author":"De Luca","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib50","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1016\/j.tet.2003.09.001","article-title":"Amide rotamers of N-acetyl-1,3-dimethyltetrahydroisoquinolines: synthesis, variable temperature NMR spectroscopy and molecular modelling","volume":"59","author":"de Koning","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2015.07.049_bib51","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.bmcl.2010.07.051","article-title":"Crystal structure of the C183S\/C217S mutant of human CA VII in complex with acetazolamide","volume":"20","author":"Di Fiore","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.07.049_bib52","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/jm501314c","article-title":"Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups","volume":"57","author":"Bozdag","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib53","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1016\/j.bmcl.2005.06.055","article-title":"Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides","volume":"15","author":"Nishimori","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.07.049_bib54","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/jm050483n","article-title":"Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors","volume":"48","author":"Nishimori","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib55","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.bmcl.2006.12.113","article-title":"Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions","volume":"17","author":"Innocenti","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2015.07.049_bib56","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/jm0512600","article-title":"Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs","volume":"49","author":"Nishimori","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2015.07.049_bib57","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1107\/S0909049512006395","article-title":"Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin","volume":"19","author":"Mueller","year":"2012","journal-title":"J.\u00a0Synchrotron Rad."},{"key":"10.1016\/j.ejmech.2015.07.049_bib58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. Sect. D-Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2015.07.049_bib59","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1107\/S0021889812011715","article-title":"XDSAPP: a graphical user interface for the convenient processing of diffraction data using XDS","volume":"45","author":"Krug","year":"2012","journal-title":"J.\u00a0Appl. Crystall."},{"key":"10.1016\/j.ejmech.2015.07.049_bib60","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1107\/S090744499900846X","article-title":"Integration of macromolecular diffraction data","volume":"55","author":"Leslie","year":"1999","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2015.07.049_bib61","series-title":"Proceedings of the CCP4 Study Weekend. Data Collection and Processing","first-page":"114","author":"Evans","year":"1993"},{"key":"10.1016\/j.ejmech.2015.07.049_bib62","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","year":"1994","journal-title":"Acta Crystallogr. Sect.D"},{"key":"10.1016\/j.ejmech.2015.07.049_bib63","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1107\/S0907444904011679","article-title":"PRODRG: a tool for high-throughput crystallography of protein-ligand complexes","volume":"60","author":"Schuttelkopf","year":"2004","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2015.07.049_bib64","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2015.07.049_bib65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by calpha geometry: phi,psi and cbeta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2015.07.049_bib66","series-title":"Discovery Studio, Accelrys","year":"2009"},{"key":"10.1016\/j.ejmech.2015.07.049_bib67","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J.\u00a0Mol. Biol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415301811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523415301811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:28:51Z","timestamp":1589560131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523415301811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":67,"alternative-id":["S0223523415301811"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.07.049","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2015.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}